Trials / Conditions / Allogeneic Hematopoietic Cell Transplant

Allogeneic Hematopoietic Cell Transplant

5 registered clinical trials studyying Allogeneic Hematopoietic Cell Transplant — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-en NCT06705062	Shanghai Jiao Tong University School of Medicine	Phase 3
Recruiting	A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases NCT04554914	Pierre Fabre Medicament	Phase 2
Completed	Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/ NCT04926194	University Health Network, Toronto	Phase 2
Recruiting	A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphopro NCT03394365	Pierre Fabre Medicament	Phase 3
Completed	A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogene NCT01903928	Astellas Pharma Inc	Phase 2